We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

93 hedge funds and large institutions have $2.39B invested in Stoke Therapeutics in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

842% more call options, than puts

Call options by funds: $4.78M | Put options by funds: $507K

106% more capital invested

Capital invested by funds: $1.16B → $2.39B (+$1.23B)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

28% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 25

6% more funds holding

Funds holding: 88 → 93 (+5)

3.25% more ownership

Funds ownership: 104.19% → 107.44% (+3.2%)

Holders
93
Holders Change
+5
Holders Change %
+5.68%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
16
Increased
32
Reduced
25
Closed
11
Calls
$4.78M
Puts
$507K
Net Calls
+$4.27M
Net Calls Change
+$2.79M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$76.1M
2
Goldman Sachs
Goldman Sachs
New York
+$21.5M
3
BlackRock
BlackRock
New York
+$19.4M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.4M
5
ALSV
ATP Life Science Ventures
New York
+$17.2M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$4.58M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.44M
3
VOYA Investment Management
VOYA Investment Management
Georgia
-$3.21M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.83M
5
Aviva
Aviva
United Kingdom
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
Canada Life
76
Canada Life
Manitoba, Canada
$46K – – –
Pacer Advisors
77
Pacer Advisors
Pennsylvania
$26K +$19.6K +427 New
EWM
78
Endurance Wealth Management
Rhode Island
$24K – – –
Osaic Holdings
79
Osaic Holdings
Arizona
$19K – – –
HPC
80
HM Payson & Co
Maine
$18K -$3.62K -79 -21%
CFGS
81
Concourse Financial Group Securities
Alabama
$12K – – –
QT
82
Quantbot Technologies
New York
$12K – – –
VAIA
83
Virtus Alternative Investment Advisers
Connecticut
$10K -$7.29K -159 -49%
First Manhattan
84
First Manhattan
New York
$9K – – –
VFA
85
Valeo Financial Advisors
Indiana
$8K – – –
SO
86
STRS Ohio
Ohio
$6K – – –
RE
87
RBC Europe
United Kingdom
$5.7K – – –
Royal Bank of Canada
88
Royal Bank of Canada
Ontario, Canada
$5K +$3.53K +77 New
AIM
89
Anchor Investment Management
South Carolina
$4.09K – – –
Daiwa Securities Group
90
Daiwa Securities Group
Japan
$4K -$5.36K -117 -63%
TFA
91
Toth Financial Advisory
Virginia
$4K – – –
IRC
92
Investors Research Corp
Georgia
$3K +$733 +16 +47%
AIG
93
American International Group
New York
$447 -$4.26K -93 -1%
Wellington Management Group
94
Wellington Management Group
Massachusetts
– -$1.83M -54,750 Closed
Point72 Asset Management
95
Point72 Asset Management
Connecticut
– -$1.31M -39,244 Closed
SG Americas Securities
96
SG Americas Securities
New York
– -$855K -25,526 Closed
Squarepoint
97
Squarepoint
New York
– -$363K -10,837 Closed
Jacobs Levy Equity Management
98
Jacobs Levy Equity Management
New Jersey
– -$224K -6,683 Closed
Principal Financial Group
99
Principal Financial Group
Iowa
– -$223K -6,658 Closed
Parallax Volatility Advisers
100
Parallax Volatility Advisers
California
– -$157K -4,702 Closed
1 2 3
4
5

STOK Hedge Fund Activity: Q4 2020 in Review

93 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q4 2020, worth a combined $2.39B — up 106% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new STOK positions and 11 closed out — a net gain of 5 holders — while 32 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $76.1M. The largest seller was Cormorant Asset Management, cutting an estimated $4.58M.

  • 93 institutional investors held Stoke Therapeutics (STOK) as of Q4 2020, up from 88 in Q3 2020.
  • Funds reported $2.39B of Stoke Therapeutics stock for Q4 2020, up 106% quarter-over-quarter.
  • 16 funds opened new Stoke Therapeutics positions in Q4 2020 and 11 closed out, a net change of +5 holders.
  • The largest Stoke Therapeutics buyer in Q4 2020 was Fidelity Investments, an estimated $76.1M added.
  • The largest Stoke Therapeutics seller in Q4 2020 was Cormorant Asset Management, an estimated $4.58M sold.

Based on aggregated 13F filings for Q4 2020.